Enzychem Lifesciences: Filing of Lawsuit (Management Dispute) (Injunction to Suspend Duties)

September 11, 2026 · KOSDAQ · Market cap ₩83.8bn · Enzychem Lifesciences chart & price →
AI reading
★★★★★ Neutral · Change in control

Application for injunction to suspend director's duties due to management dispute

Key figures: Value of Subject Matter: ₩100M

An AI model read the opening section of the filing and rated it relative to the company's size. It can be wrong, so check the original filing on DART (Korean).

All of today's important filings (Filings Radar) →

For information only. Not investment advice.